ArticlePDF Available

Frequency of Bleeding Duodenal Ulcer in Patients Presenting with Upper Gastrointestinal Bleeding: Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding

Authors:

Abstract

Acute upper gastrointestinal bleeding is a well-known complication of peptic ulcers and erosions. The prevalence of Upper Gastrointestinal bleeding ranges from 48-160 patients per 100,000 people, with consistent reports of higher incidence among elderly and men. Objective: To determine the incidence of duodenal ulcer bleeding in patients admitted to the tertiary care hospital with bleeding from the upper gastrointestinal tract. Methods: The study included 270 patients, 20 to 70 years of age, of both sexes with upper gastrointestinal bleeding within 24 hours of symptom onset. A detailed interview and complete physical examination were performed. Endoscopic examination protocols were followed and accomplished within 48-hrs of the start of symptoms as bleeding. All of the above information, including age, sex and duodenal ulcer, was documented in a formerly designed proforma. The data were analyzed and entered in SPSS 22.0. Results: The mean age and SD were 54.5 + 10.54. 110 (40.74%) patients were 20-45 years old and 160 (59.25%) subjects were 46-70 years old. 190 (70.37%) patients were male and 80 (29.62%) females. While in this study duodenal ulcer was seen in 64 (23.70%) patients, 206 (76.29%) patients did not have duodenal ulcer. Conclusions: Upper Gastrointestinal bleeding is secondary to duodenal ulcers due to an increase in early readmissions over time, as observed in this local population, resulting in a higher incidence of duodenal ulcers in our local population.
Original Article
Bleeding from the upper gastrointestinal tract is a
communal symptom i n m ed ical i ns tituti ons a nd
gastroenterology clinics [1]. It has multiple causes that
varies greatly in different geographic regions of the world
[2]. De sp ite d evel op men ts i n t re at me nt , u pp er
gastrointestinal bleeding secondar y to peptic ulcer
remains a serious medical risk with signicant mortality,
morbidity and healthcare costs. The peptic ulcer disease is
ass umed to be reduced due to im prov ements in
endoscopic techniques, decreased Helicobacter pylori
DOI: https://doi.org/10.54393/pjhs.v3i06.308
Fahim M et al.,
Frequency of Bleeding Duodenal Ulcer in Patients presenting with Upper
Gastrointestinal Bleeding
1 2 3 4* 2
Muhammad Fahim, Muhammad Sohail , Muhammad Sajjad Khan , Fahim Ullah Khan , Salman ur Rashid , Shakeel
5
Akhter
¹MTI, Mardan Medical Complex, Mardan, Pakistan
²Primary Health Services Mardan, Pakistan
³Primary Health Services Bannu, Pakistan
⁴Primary Health Services D.I.Khan, Pakistan
⁵MTI, Bacha Khan Medical Complex Swabi, Pakistan
incidence and an increased use of acid-inhibiting drugs.
However, advances in peptic ulcer treatment have not
necessarily reduced the number of hospitalizations for
upper gastrointestinal bleeding following peptic ulcer
disease or the risk of adverse events, counting mortality.
Conicts in previous studies results can be claried by
various factors. Gastric ulcer epidemiology has evolved and
is no longer driven by H. pylori. An aging population has
increased use of non-steroidal anti-inammatory drugs
(NSAIDs), counting aspirin. This results in more frequent
Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding
I N T R O D U C T I O N
Acute upper gastrointestinal bleeding is a well-known complication of peptic ulcers and
erosions. The prevalence of Upper Gastrointestinal bleeding ranges from 48-160 patients per
100,000 people, with consistent reports of higher incidence among elderly and men. Objective:
To determine the incidence of duodenal ulcer bleeding in patients admitted to the tertiary care
hospital with bleeding from the upper gastrointestinal tract. Methods: The study included 270
patients, 20 to 70 years of age, of both sexes with upper gastrointestinal bleeding within 24
hours of symptom onset. A detailed inter view and complete physical examination were
performed. Endoscopic examination protocols were followed and accomplished within 48-hrs
of the start of symptoms as bleeding. All of the above information, including age, sex and
duodenal ulcer, was documented in a formerly designed proforma. The data were analyzed and
entered in SPSS 22.0. Results: The mean age and SD were 54.5 + 10.54. 110 (40.74%) patients
were 20-45 years old and 160 (59.25%) subjects were 46-70 years old. 190 (70.37%) patients were
male and 80 (29.62%) females. While in this study duodenal ulcer was seen in 64 (23.70%)
patients, 206 (76.29%) p atie nts did not ha ve du oden al u lcer. Conclusions: U pper
Gastrointestinal bleeding is secondary to duodenal ulcers du e to an in crease in early
readmissions over time, as observed in this local population, resulting in a higher incidence of
duodenal ulcers in our local population.
A R T I C L E I N F O A B S T R A C T
How to Cite:
Fahim, M. ., Sohail, M. ., Sajjad Khan, M., Khan, F. U. .,
Ur Rashid, S. ., & Akhter, S. . (2022). Frequency of
Bleeding Duodenal Ulcer in Patients Presenting with
Upp er Gas trointest inal B leedi ng: Frequ ency of
Duodena l Ulcer in pati ents with Gastrointestinal
Bleeding. Pakistan Journal of Health Sciences, 3(06).
https://doi.org/10.54393/pjhs.v3i06.308
Key Words:
Gast rointestina l surge ry, Peptic ulcer bleedi ng,
Endoscopy and Mortality
*Corresponding Author:
Fahim Ullah Khan
Primary Health Services, D.I.Khan, Pakistan
fahimkhan757@gmail.com
Received Date: 31th October, 2022
th
Acceptance Date: 15 November, 2022
th
Published Date: 30 November, 2022
PAKISTAN JOURNAL OF HEALTH SCIENCES
https://thejas.com.pk/index.php/pjhs
Volume 3, Issue 6 (November 2022)
PJHS VOL. 3 Issue. 6 November 2022
Copyright © 2022. PJHS, Published by Crosslinks International Publishers
88
bleeding from the upper gastrointestinal tract following
peptic ulcer disease in the elderly people. The utmost
communal symptoms are bloody vomiting in acute bleeding
and melaena in cases which were chronic. It has been
observed that duodenal ulcer is common in cirrhosis
patients than in the over-all population [3]. In previous
years, most bleeding in patients with cirrhosis was
attributed to esophageal varices [4]. The widespread use
of upper gastrointestinal endoscopy has shown that in
many cases it can cause erosions, gastritis, or other
injuries such as peptic ulcers, especially duodenal ulcers
[5]. The prevalence of upper gastrointestinal bleeding
ranges from 48-160 patients per 100,000 people, with
consistent reports of higher incidence among elderly and
men [6]. The acute upper gastrointestinal bleeding most
communal reason is not varicose veins, and bleeding from
peptic ulcer (PIU) accounts for 28% to 59% of cases [7].
Most peptic ulcer disease patients are successfully treated
by H. pylori infection treatment and / or using suitable
antisecretory therapy and avoiding NSAIDs usage [8]. In
USA, triple therapy based on proton pump inhibitors (PPIs)
is the recommended primary treatment for H. pylori
infection. Peptic ulcers are defects in the lining of the
duodenum or stomach that cover along the mucosal
membrane [9]. The gastric and duodenal epithelial cells
secrete mucus as a consequence of the cholinergic
stimulation and epithelial lining irritation. The supercial
part of the duodenal and gastric mucosa is in the gel layer
form that is not-permeable to pepsin and acids. Other cells
in the stomach and duodenum secrete bicarbonate, which
helps buffer the acid near the mucosa [10]. Type E
prostaglandins (PGEs) play a vital protective part as PGEs
increase the secret ion of bo th m ucosal layer a nd
bicarbonate [11]. The aim of the study was to govern the
incidence of duodenal ulcer bleeding in patients admitted
to the tertiary care hospital with bleeding from the upper
gastrointestinal tract in order to determine the morbidity
and mortality associated with duodenal ulcer in our local
population. No comparable analysis has been performed at
our facility in the previous 5-years, this analysis will provide
the most up-to-date and latest information on the
frequency of duodenal ulcer bleeding in upper GI bleeding
patients. This study outcomes will be benecial for other
healthcare professionals and can be the reference for
further studies.
assessment were performed. Inclusion Criteria: All
pati ents reporting upper gastroi ntestinal bleeding
reporting within 24 hours of symptom onset, Patients aged
20-70, Patients of both sexes. Exclusion criteria: Patients
with severe shock (BP 90/160), patients with coagulation
disorders, recent myocardial infarction, severe respiratory
disease, arrhythmias or unstable angina were omitted from
the study. Hospital ethics committee approval and
approval from CPSP REU department were obtained. A
detailed interview and complete physical examination
were performed. Endoscopic examination protocols were
followed. Compulsory baseline tests, including complete
blood count, were obtained; occult blood faeces, eggs /
cysts; bleeding prole; hepatitis serology; ECG, abdominal
ultrasound, X-ray chest at admission before the procedure.
Patients were registered for endoscopic evaluation of the
upper gastrointestinal tract after obtaining informed
consent. Upper gastrointestinal endoscopy was
accomplished within 48-hrs of the start of symptoms as
bleeding. Local anesthesia of the throat was provided with
a 4% xylocaine spray. The entire procedure was performed
under the supervision of a gastroenterologist with at least
ve years of experience. All of the above information,
including age, sex and duodenal ulcer, was documented in a
formerly designed proforma. The data were analyzed and
entered in SPSS 22.0. Means and S.D were calculated for
quantitative variables such as size of the lesion and age.
The frequency and percentages were calculated by gender
and bleeding duodenal ulcer. Duodenal ulcer was graded
with gender and age to determine the effect modication.
The chi-square te st was used after s trati cation,
considering the P value <0.05 as signicant. All results are
presented in graphs and tables.
R E S U L T S
270 total patients of both sexes, 20 to 70 years of age,
selected by sequential sampling of improbable samples
with bleeding from the upper gastrointestinal tract within
24 hours of symptom onset, were registered in the study. A
comp rehensive in terview and complete physica l
M E T H O D S
Age Group
Table 1: Shows the patients demographic features (n=270)
Th e stud y was condu cted on 270 p ati ents at the
Department of Gastroenterology at MTI-Lady Reading
Hospital in Peshawar. The results are given below: - Mean
and SD for age were 54.5 ± 10.54. 110 (40.74%) patients were
20-45 years old and 160 (59.25%) patients were 46-70 years
old. 190 (70.37%) patients were male and 80 (29.62%)
females. (Table 1).
Frequency (%)
20-45 Years
46-70 Years
Total
110 (40.74%)
160 (59.26%)
270 (100%)
Male
Female
Total
Mean age
190 (70.37%)
80 (29.62%)
270 (100%)
54.5 ± 10.54 SDs
Gender
DOI: https://doi.org/10.54393/pjhs.v3i06.308
Fahim M et al., Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding
PJHS VOL. 3 Issue. 6 November 2022
Copyright © 2022. PJHS, Published by Crosslinks International Publishers
89
While in this study duodenal ulcer was registered in 64
(23.70%) patients, 206 (76.29%) patients did not have
duodenal ulcer. (Table 2).
study duodenal ulcer was seen in 64 (23.70%) patients, 206
(76.29%) patients did not have duodenal ulcer. Of these
ulcers, 45 (6.5%) were graded as Forrest I and Forrest II was
seen in 113 (16.2%) cases. Gastric ulcer was identied in 488
cases (2.5%), and symptoms of bleeding were observed in
61 cases (12.3%) in Fallah et al., study [14]. Compared to this
study, where the mean age and SD was 54.5 ± 10.54, 19
patients (3.9%) have Forrest 1 grading and 41 patients
(8.4%) had Forrest 2. The gastric ulcers incidence
remained stable over time, while the duodenal ulcers
incidence decreased [15, 16]. It has been observed that
duodenal ulcer is common in cirrhosis patients than in the
over-all population. In previous years, most bleeding in
patients with cirrhosis was attributed to esophageal
varices. The widespread use of upper gastrointestinal
endoscopy has shown that in many cases it can cause
erosions, gastritis, or other injuries such as peptic ulcers,
especially duodenal ulcers. The prevalence of upper
gastrointestinal bleeding ranges from 48-160 patients per
100,000 peo ple, w ith consiste nt reports of hi gher
incidence among elderly and men. The acute upper
gastrointestinal bleeding most communal reason is not
varicose veins, and bleeding from peptic ulcer accounts for
28% to 59% of cases. Most peptic ulcer disease patients
are successfully treated by H. pylori infection treatment
and / or using suitable antisecretory therapy and avoiding
NSAIDs usage. In USA, triple therapy based on proton pump
inhibitors (PPIs) is the recommended primary treatment for
H. pylori infection [17, 18]. In this study, patients with
bleeding duodenal ulcers had a worse prognosis than
patients with bleeding gastric ulcers. Duodenal ulcers were
associated w ith increas ed m ort ality, surger y, and
admission rates [19, 20]. Bleeding from duodenal ulcers
has been related with an augmented risk of mortality and
surgery in some, but not all as shown in previous studies
[21, 22]. Duodenal ulcers may be associated with a poorer
prognosis as duodenal ulcers may be technically more
dicult to manage; especially in the case of endoscopy
performed in rural areas with little experience in the
treatment of upper gastrointestinal bleeding secondary to
peptic ulcer disease [6, 23].
C O N C L U S I O N S
Bleeding from the upper gastrointestinal tract is a
communal symptom i n m ed ical i ns tituti ons a nd
gastroenterology clinics. It has multiple causes that varies
greatly in different geographic regions of the world. The
utmost communal symptoms are bloody vomiting in acute
bleeding and melaena in cases which were chronic. In this
study, the mean age and SD were 54.5 + 10.54. 110 (40.74%)
patients were 20-45 years old and 160 (59.25%) patients
were 46-70 years old. 190 (70.37%) patients were male and
80 (29.62%) females. While in this study duodenal ulcer was
registered in 64 (23.70%) patients, 206 (76.29%) patients
did not have duodenal ulcer. In total, 20,006 upper GI
endoscopies were accomplished in one study [12, 13].
Duodenal ulcer was diagnosed in 696 (3.5%) cases and
bleeding symptoms were observed in 158 (22.7%) cases,
mean and SD for age was 54.5 + 10.54 compared to this
study. 110 (40.74%) patients were 20-45 years old and 160
(59.25%) patients were 46-70 years old. 190 (70.37%)
patients were male and 80 (29.62%) females. While in this
D I S C U S S I O N
Table 2: Frequency and Percentages for Duodenal Ulcer (n=270)
Upper gastrointestinal bleeding is secondary to duodenal
ulcers due to an increase in early readmissions over time,
as observed in this local population, resulting in a higher
incidence of duodenal ulcers in our local population. The
limitation of this study was the six-month period, which
was too short to meaningfully assess the time trends in our
local population.
Duodenal Ulcer Frequency (%)
Yes
No
Total
64 (23.70%)
206 (76.29%)
270 (100%)
Age and Gender was controlled through stratication and
therefore can be seen at Table 3 and 4 respectively. Table 3
shows the incidence of duodenal ulcer with respect to the
age; 14(5.18%) subjects out of 110 were found positive for
duodenal ulcer in 20-45 years of age while 50(18.51%)
patients out of 160 have duodenal ulcer in 20-45 years of
age patients.
Age P Value
Yes
No
Yes
No
14 (05.18%)
96 (35.55%)
50 (18.51%)
110 (40.74%)
Duodenal Ulcer Frequency (%)
20-45 Years
46-75 Years
0.0004
Table 3: Stratication of Duodenal Ulcer with Age (N=270)
Table 4 shows the incidence of duodenal ulcer with respect
to the gender; 39(14.4%) male subjects out of 190 were
found positive for duodenal ulcer while 25(9.25%) female
patients out of 80 have duodenal ulcer.
Gender P Value
Yes
No
Yes
No
39 (14.44%)
151 (55.92%)
25 (09.25%)
55 (12.96%)
Duodenal Ulcer Frequency (%)
Male
Female
0.058
Table 4: Stratication of Duodenal Ulcer with Gender (N=270)
C o n i c t s o f I n t e r e s t
The authors declare no conict of interest
DOI: https://doi.org/10.54393/pjhs.v3i06.308
Fahim M et al., Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding
PJHS VOL. 3 Issue. 6 November 2022
Copyright © 2022. PJHS, Published by Crosslinks International Publishers
90
The author(s) received no nancial support for the
research, authorship and/or publication of this article.
Nunziale A, Bertini L, et al. Prospective study
comparing multi-detector row CT and endoscopy in
acute gastrointestinal bleeding. World Journal of
Surgery. 2009 Oct; 33(10):2209-17. doi: 10.1007/
s00268-009-0156-6.
Lam KL, Wo ng JC, Lau JY. Pha rmaco logic al
treatment i n upper gastrointestinal bleeding.
Current Treatment Options in Gastroenterology. 2015
Dec; 13(4):369-76. doi: 10.1007/s11938-015-0063-x.
Curdia-Goncalves T, Rosa B, Cotter J. New insights
on an ol d m edi ca l em er ge ncy: no n-p or tal
hy perten sion relat ed uppe r g astr ointe stinal
bleeding. Revist a es panola de enfe rmedad es
digestivas. 2016 Oct; 108(10):648-56. doi: 10.17235/
reed.2016.4240/2016.
Lirio RA. Management of upper gastrointestinal
bleeding in children: variceal and nonvariceal.
Ga stro inte sti nal End osco py Clin ics o f North
America. 2016 Jan; 26(1):63-73. doi: 10.1016/j.giec.
2015.09.003.
Fallah MA, Pra kash C, Edmundowicz S. Acute
gastrointestinal bleeding. Medical Clinics of North
America. 2000 Sep; 84(5):1183-208. doi: 10.1016/
s0025-7125(05)70282-0.
Pongpr aso bch ai S , Nim itv ila i S, C has awat J,
Manatsathit S. Upper gastrointestinal bleeding
etiology score for predicting variceal and non-
variceal bleeding. World Journal of Gastroenterology.
2009 Mar; 15(9):1099-104. doi: 10.3748/wjg.15.1099.
Straube S, Tramer MR, Moore RA, Derry S, McQuay HJ.
Mortality with upper gastrointestinal bleeding and
perforation: effects of time and NSAID use. BMC
Gastroenterology. 2009 Jun; 9:41. doi: 10.1186/1471-
230X-9-41.
Yavorski RT, Wong RK, Maydonovitch C, Battin LS,
Furnia A, Amundson DE. Analysis of 3,294 cases of
upper gastrointestinal bleeding in military medical
facilities. The American Journal of Gastroenterology.
1995 Apr; 90(4):568-73.
Stabile BE and Stamos MJ. Surgical management of
gastrointestinal bleeding. Gastroenterology Clinics
of North America. 2000 Mar; 29(1):189-222. doi: 10.
1016/s0889-8553(05)70112-6.
Cheung FK and Lau JY. Management of massive
peptic ulcer bleeding. Gastroenterology Clinics of
North America. 2009 Jun; 38(2):231-43. doi: 10.1016/j.
gtc.2009.03.003.
Tiriveedhi K, Simon J, Cerulli MA. Does gastric lavage
reduce the detection of Helicobacter pylori in the
biopsy specimens? Gastrointestinal Endoscopy.
2007 Apr; 65(5):AB312. doi: 10.1016/j.gie.2007.03.756.
Boonpongmanee S, Fleischer DE, Pezzullo JC, Collier
Farrukh S, Raja S, Junaid K, Sahibzada NM, Naseer A.
F re q ue nc y o f d if fe r en t c au se s o f u pp er
gastro in testinal bleeding using endoscopic
procedure at a tertiary care hospital. Causes of Upper
Gastrointestinal Bleeding. Pakistan Armed Forces
Medical Journal. 2014 Sep; 64(3):410-413.
Marcel
JM, Ernst JK, Bettina EH, Rob JT. Incidence of
duodenal ulcers and gastric ulcers in a Western
population: Back to where it started. Canadian
Journal of Gastroenterology. 2009 Sep; 23(9):604–
08. doi: 10.1155/2009/181059.
Farah S, Rizwan A, Muhammad A. Frequency of
duodenal ulcer in cirrhosis of liver. Pakistan Journal
of Medical Health Sciences. 2010 Jan; 4(1):56-60.
Budimir I, Stojsavljevic S, Nikolic M, Kralj D, Biscanin
A, K iri gin LS , e t a l. Bl ee din g p ep tic ul ce r:
epidemiology, treatment and prognosis. Acta Clinica
Croatica. 2017 Dec; 3(1):1007. doi: 10.20471/acc.
2017.56.04.18.
Ch ey WD and Wong BC. Amer ica n col leg e of
gastroenterology guideline on the management of
helicobacter pylori infection. The American Journal
of Gastroenterology. 2014 Aug; 102(8):1808-25. doi:
10.1111/j.1572-0241.2007.01393.x.
Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW.
Causes of mortality in patients with peptic ulcer
bleeding: a prospective cohort study of 10,428 cases.
The American Journal of Gastroenterology. 2010 Jan;
105(1):84-9. doi: 10.1038/ajg.2009.507.
Quan S, Frolkis A, Milne K, Molodecky N, Yang H ,
Dixon E, et al. Upper-gastrointestinal bleeding
secondary to peptic ulcer disease: Incidence and
outcomes. World Journal of Gastroenterology. 2014
Dec; 20(46):17568–577. doi: 10.3748/wjg.v20.i46.
17568.
Gralnek IM, Dumonceau JM, Kuipers EJ. Diagnosis
a n d m a n ag e me n t o f n o nv a ri c ea l u pp e r
gastrointestinal hemorrhage: European Society of
Gastrointest inal E ndosc opy (ESGE) Guideline.
Endoscopy. 2015 Oct; 47(10):a1-a46. doi: 10.1055/s-
0034-1393172.
al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer
site and complications: relation to Helicobacter
pylori infection and NSAID use. Endoscopy. 1996 Feb;
28(2):229-33. doi: 10.1055/s-2007-1005433.
Frattaroli FM, Casciani E, Spoletini D, Polettini A,
S o u r c e o f F u n d i n g
REFERENCES
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
DOI: https://doi.org/10.54393/pjhs.v3i06.308
Fahim M et al., Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding
PJHS VOL. 3 Issue. 6 November 2022
Copyright © 2022. PJHS, Published by Crosslinks International Publishers
91
K, Mayoral W, Al-Kawas F, et al. The frequency of
peptic ulcer as a cause of upper-GI bleeding is
exaggerated. Gastrointestinal Endoscopy. 2004 Jun;
59(7):788-94. doi: 10.1016/S0016-5107(04)00181-6.
Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P,
Laine L. Systematic review of the predictors of
recurrent hemorrhage after endoscopic hemostatic
therapy for bleeding peptic ulcers. The American
Journal of Gastroenterology. 2008 Oct; 103(10):2625-
32. doi: 10.1111/j.1572-0241.2008.02070.x.
Leaper DJ. Surgery JD Corson RCN Williamson (eds)
297 × 254 mm Pp 1660 Illustrated 2001 London: Mosby.
British Journal of Surgery. 2002 Nov; 88(9):1269. doi:
10.1046/j.0007-1323.2001.01887.x
[22]
[23]
DOI: https://doi.org/10.54393/pjhs.v3i06.308
Fahim M et al., Frequency of Duodenal Ulcer in patients with Gastrointestinal Bleeding
PJHS VOL. 3 Issue. 6 November 2022
Copyright © 2022. PJHS, Published by Crosslinks International Publishers
92
... 3,4 The clinical signs and symptoms of acute UGIB include hematemesis, melena, hematochezia, syncope, dyspepsia, diffuse abdominal pain, dysphagia, weight loss, and jaundice. 5 The incidence of UGIB is approximately 100 cases per 100,000 individuals per year. Bleeding from the upper GI tract is about four times more common than lower GI tract bleeding and represents a major cause of morbidity and mortality. ...
... Despite this, the death rate is similar between the sexes. 5,8 Even with therapeutic advances, in-hospital mortality remains significant at 13%, and re-bleeding occurs in 15% of cases. 9 In patients with UGIB, comorbidities rather than the bleeding itself are often the primary cause of death. ...
Article
Background: Upper GI bleeding significantly impacts patients with liver cirrhosis, increasing morbidity and mortality. While variceal bleeding is the most common cause, nonvariceal bleeding presents a higher risk of severe endoscopic stigmata, potentially leading to greater complications. Objective: To assess the prevalence of liver cirrhosis in acute upper GI bleeding patients and its correlation with other factors. Study Design: Descriptive cross-sectional study. Settings: Department of General Medicine, Medical Teaching Institute, Khyber Teaching Hospital, Peshawar Pakistan. Duration: 25 Jul 2021 to 25 Jan 2022. Methods: This study included 195 acute upper GI bleeding patients, selected via nonprobability sampling. Patients aged 18–70 years were analyzed through clinical history, lab tests, ultrasounds, and endoscopies by specialists. Data was processed using SPSS 20, with numerical and categorical variables evaluated. Results: The study included 195 patients, 53.8% of whom had liver cirrhosis. The mean age was 44.38±15.23 years, with 54.4% male. Hepatitis C was more prevalent (55.4%) than Hepatitis B (44.6%). Smoking was common (67.2%), while 9.2% reported IV drug abuse. No significant associations were found between liver cirrhosis and age (P=0.178), gender (P=0.080), viral hepatitis type (P=0.739), smoking (P=0.279), IV drug abuse (P=0.879), or BMI (P=0.841). Conclusion: This study found a high incidence of liver cirrhosis in acute upper GI bleeding patients. A multidisciplinary strategy emphasizing early diagnosis and timely intervention is crucial for better outcomes.
Article
Full-text available
Upper gastrointestinal bleeding (UGIB) is a potentially life-threatening condition and is the most common medical emergency managed by gastroenterologists. Despite being one of the most antique medical problems, recent studies have been slowly changing the management of these patients, which should nowadays include not only initial resuscitation, but also risk stratification, pre-endoscopic therapy, endoscopy treatment, and post-procedure care. The aim of this paper is to review the extended approach to the patient with non-portal hypertension related UGIB.
Article
Full-text available
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH).
Article
Full-text available
Objectives: To assess the outcome of early endoscopy in terms of frequency of different causes of upper gastrointestinal bleeding at a tertiary care hospital. Patients and Methods: Study was carried out in department of medicine Military Hospital Rawalpindi. Two hundred and forty four after cosen. Patients of upper gastrointestinal bleeding fulfilling the inclusion criteria were included in the study. Haemodynamically stable patients were kept empty stomach for at least 6-8 hours before procedure. A detailed history and thorough physical examination was carried out. Protocols for endoscopic examination were followed. Mandatory baseline investigations were obtained. Endoscopic findings were documented on a proforma. p value of less than 0.05 was considered statistically significant. Results: There were 174 males (71.3%) and 70 females (28.7%). The age of the patients ranged from 15 years to 75 years, mean age was 52.23 years (SD = 14.78). The most common cause of upper GI bleed was varices in 176 (72.1%) patients; followed by gastric ulcer in 24 (9.8%) patients. Other causes in order of decreasing frequency included gastritis 16(6.55%), duodenal ulcer 14(5.73%), esophagitis 6(2.45%), Mallory Weiss tear 2(0.81%) and miscellaneous 6(2.45%). Conclusion: Esophageal varices is the most common cause of upper GI bleed in our set up reflecting high prevalence of liver cirrhosis secondary to chronic HBV and HCV infection.
Article
Full-text available
To evaluate the incidence, surgery, mortality, and readmission of upper gastrointestinal bleeding (UGIB) secondary to peptic ulcer disease (PUD). Administrative databases identified all hospitalizations for UGIB secondary to PUD in Alberta, Canada from 2004 to 2010 (n = 7079) using the International Classification of Diseases Codes (ICD-10). A subset of the data was validated using endoscopy reports. Positive predictive value and sensitivity with 95% confidence intervals (CI) were calculated. Incidence of UGIB secondary to PUD was calculated. Logistic regression was used to evaluate surgery, in-hospital mortality, and 30-d readmission to hospital with recurrent UGIB secondary to PUD. Co-variants accounted for in our logistic regression model included: age, sex, area of residence (i.e., urban vs rural), number of Charlson comorbidities, presence of perforated PUD, undergoing upper endoscopy, year of admission, and interventional radiological attempt at controlling bleeding. A subgroup analysis (n = 6356) compared outcomes of patients with gastric ulcers to those with duodenal ulcers. Adjusted estimates are presented as odds ratios (OR) with 95%CI. The positive predictive value and sensitivity of ICD-10 coding for UGIB secondary to PUD were 85.2% (95%CI: 80.2%-90.2%) and 77.1% (95%CI: 69.1%-85.2%), respectively. The annual incidence between 2004 and 2010 ranged from 35.4 to 41.2 per 100000. Overall risk of surgery, in-hospital mortality, and 30-d readmission to hospital for UGIB secondary to PUD were 4.3%, 8.5%, and 4.7%, respectively. Interventional radiology to control bleeding was performed in 0.6% of patients and 76% of these patients avoided surgical intervention. Thirty-day readmission significantly increased from 3.1% in 2004 to 5.2% in 2010 (OR = 1.07; 95%CI: 1.01-1.14). Rural residents (OR rural vs urban: 2.35; 95%CI: 1.83-3.01) and older individuals (OR ≥ 65 vs < 65: 1.57; 95%CI: 1.21-2.04) were at higher odds of being readmitted to hospital. Patients with duodenal ulcers had higher odds of dying (OR = 1.27; 95%CI: 1.05-1.53), requiring surgery (OR = 1.73; 95%CI: 1.34-2.23), and being readmitted to hospital (OR = 1.54; 95%CI: 1.19-1.99) when compared to gastric ulcers. UGIB secondary to PUD, particularly duodenal ulcers, was associated with significant morbidity and mortality. Early readmissions increased over time and occurred more commonly in rural areas.
Article
Full-text available
As recently as 40 years ago, a decline in the incidence of peptic ulcers was observed. The discovery of Helicobacter pylori had a further major impact on the incidence of ulcer disease. Our aim was to evaluate the trends in the incidence and bleeding complications of ulcer disease in the Netherlands. From a computerized endoscopy database of a district hospital, the data of all patients who underwent upper gastrointestinal endoscopy from 1996 to 2005 were analyzed. The incidence of duodenal and gastric ulcers, with and without complications, were compared over time. Overall, 20,006 upper gastrointestinal endoscopies were performed. Duodenal ulcers were diagnosed in 696 (3.5%) cases, with signs of bleeding in 158 (22.7%). Forty-five (6.5%) of these ulcers were classified as Forrest I and 113 (16.2%) as Forrest II. Gastric ulcers were diagnosed in 487 cases (2.4%), with signs of bleeding in 60 (12.3%). A Forrest 1 designation was diagnosed in 19 patients (3.9%) and Forrest 2 in 41 patients (8.4%). The incidence of gastric ulcers was stable over time, while the incidence of duodenal ulcers declined. The incidence of duodenal ulcer disease in the Dutch population is steadily decreasing over time. Test and treatment regimens for H pylori have possibly contributed to this decline. With a further decline in the prevalence of H pylori, the incidence of gastric ulcers is likely to exceed the incidence of duodenal ulcers in the very near future, revisiting a similar situation that was present at the beginning of the previous century.
Article
Introduction: Cirrhosis of the liver is a common cause of duodenal ulcer. Liver cirrhosis results in portal hypertension, splenomegaly, esophageal varices (EV) and duodenal ulcers. Duodenal ulcer bleeding is a serious complication with significant morbidity and mortality. It has therefore been recommended that patients with liver cirrhosis should be screened for the presence of duodenal ulcer at the time of initial diagnosis ,and at periodic intervals thereafter throughout life. Duodenal ulcer can cause fatal hemorrhage in patients of cirrhosis, thus emphasizing need for surveillance of duodenal ulcer as the cause of bleeding rather than esophageal varices. This study is to see the association of duodenal ulcer in cirrhotic patients presenting in Medical Unit 1.The application of its results may help in early management of life threatening upper gastrointestinal hemorrhage. Objective: To determine the frequency of duodenal ulcers among patients of liver cirrhosis. Study Design: Cross sectional survey. Setting: Medical Unit 1, Services Hospital, Lahore. Duration with dates: The study was completed over a period of 6 months; from 20 th November 2008 to 19 th May 2009. Subjects and Methods: Hundred and thirty five patients who had coarse echotexture of liver on abdominal ultrasound,and fulfilling the inclusion criteria were enrolled in the study. These patients were then subjected to upper gastrointestinal endoscopy after informed consent and the presence and number of duodenal ulcers were noticed. Also noticed was site, size of ulcer and whether the ulcer was bleeding or not. Results: The frequency of duodenal ulcers in patients of liver cirrhosis was 9.6%. Conclusion: The study showed that duodenal ulcer was present in 9.6% patients of liver cirrhosis. Its application will help in identifying the cause of bleeding in cirrhotic patients while performing upper gastrointestinal endoscopy and will help in management.
Article
Upper gastrointestinal (UGI) bleeding is generally defined as bleeding proximal to the ligament of Treitz, which leads to hematemesis. There are several causes of UGI bleeding necessitating a detailed history to rule out comorbid conditions, medications, and possible exposures. In addition, the severity, timing, duration, and volume of the bleeding are important details to note for management purposes. Despite the source of the bleeding, acid suppression with a proton-pump inhibitor has been shown to be effective in minimizing rebleeding. Endoscopy remains the interventional modality of choice for both nonvariceal and variceal bleeds because it can be diagnostic and therapeutic.
Article
Acute upper gastrointestinal bleeding (AUGIB) is a common medical emergency. Bleeding peptic ulcers account for the majority of causes in patients presenting with AUGIB, whereas variceal bleeding in cirrhotic patients represents a more severe form of bleeding. Endoscopic therapy is the mainstay of treatment in patients with active bleeding, as it achieves hemostasis and improves patient outcomes. Pharmacotherapy is an important adjunct to endoscopic hemostasis. In the management of patients with bleeding peptic ulcers, acid suppression after endoscopic hemostasis reduces rates of further bleeding and interventions. In patients with stable hemodynamics awaiting endoscopy, acid suppression starts ulcer healing and downstages stigmata of bleeding, thereby reducing the need for endoscopic therapy. In managing patients with variceal bleeding, early administration of vasoactive drugs lowers splanchnic blood flow, promotes hemostasis, and makes subsequent endoscopic treatment easier. The use of vasoactive agents and antibiotics have both been shown to reduce mortality. In this review article, strategies of acid suppression therapy for peptic ulcer bleeds, vasoactive agents, and antibiotics for variceal bleeding, together with recent evidence on the use of tranexamic acid in gastrointestinal bleeding, are discussed.